Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.42 - $0.65 $3,197 - $4,947
-7,612 Closed
0 $0
Q1 2022

Jun 20, 2023

BUY
$0.54 - $2.74 $4,110 - $20,856
7,612 New
7,612 $4,000
Q1 2022

Mar 30, 2023

BUY
$0.54 - $2.74 $397 - $2,016
736 Added 10.7%
7,612 $4,000
Q1 2022

May 12, 2022

BUY
$0.54 - $2.74 $397 - $2,016
736 Added 10.7%
7,612 $5,000
Q4 2021

Jun 21, 2023

BUY
$2.33 - $3.37 $16,021 - $23,172
6,876 New
6,876 $18,000
Q4 2021

Mar 30, 2023

SELL
$2.33 - $3.37 $24,012 - $34,731
-10,306 Reduced 59.98%
6,876 $18,000
Q4 2021

Feb 15, 2022

SELL
$2.33 - $3.37 $24,012 - $34,731
-10,306 Reduced 59.98%
6,876 $18,000
Q3 2021

Jun 21, 2023

BUY
$2.52 - $2.99 $43,298 - $51,374
17,182 New
17,182 $47,000
Q3 2021

Mar 30, 2023

SELL
$2.52 - $2.99 $22,858 - $27,122
-9,071 Reduced 34.55%
17,182 $47,000
Q3 2021

Nov 15, 2021

SELL
$2.52 - $2.99 $22,858 - $27,122
-9,071 Reduced 34.55%
17,182 $47,000
Q2 2021

Jun 21, 2023

BUY
$2.6 - $3.65 $68,257 - $95,823
26,253 New
26,253 $74,000
Q2 2021

Mar 30, 2023

BUY
$2.6 - $3.65 $26,449 - $37,131
10,173 Added 63.26%
26,253 $74,000
Q2 2021

Aug 16, 2021

BUY
$2.6 - $3.65 $68,216 - $95,765
26,237 Added 163981.25%
26,253 $75,000
Q1 2021

Jun 26, 2023

BUY
$2.73 - $4.5 $43,898 - $72,360
16,080 New
16,080 $55.2 Million
Q1 2021

Mar 30, 2023

SELL
$2.73 - $4.5 $39,781 - $65,574
-14,572 Reduced 47.54%
16,080 $55,000
Q1 2021

May 14, 2021

SELL
$2.73 - $4.5 $83,636 - $137,862
-30,636 Reduced 99.95%
16 $55,000
Q4 2020

Jun 22, 2023

BUY
$2.6 - $3.32 $79,695 - $101,764
30,652 New
30,652 $80,000
Q4 2020

Mar 30, 2023

BUY
$2.6 - $3.32 $967 - $1,235
372 Added 1.23%
30,652 $80,000
Q4 2020

Feb 16, 2021

BUY
$2.6 - $3.32 $967 - $1,235
372 Added 1.23%
30,652 $81,000
Q3 2020

Jun 26, 2023

BUY
$2.46 - $4.27 $74,488 - $129,295
30,280 New
30,280 $94,000
Q3 2020

Mar 30, 2023

SELL
$2.46 - $4.27 $9,234 - $16,029
-3,754 Reduced 11.03%
30,280 $94,000
Q3 2020

Nov 13, 2020

SELL
$2.46 - $4.27 $9,234 - $16,029
-3,754 Reduced 11.03%
30,280 $94,000
Q2 2020

Jun 26, 2023

BUY
$1.45 - $4.3 $49,349 - $146,346
34,034 New
34,034 $140,000
Q2 2020

Mar 30, 2023

BUY
$1.45 - $4.3 $49,349 - $146,346
34,034 New
34,034 $140,000
Q2 2020

Aug 14, 2020

BUY
$1.45 - $4.3 $49,349 - $146,346
34,034 New
34,034 $141,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $372M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.